As a highly specialized life science advisory and investment banking firm, Outcome Capital looks to identify emerging trends that effect how researchers and clinicians understand, diagnose, and treat disease.
Biology and Digital Technology Merger Gives Rise to Spatial Biology
Market Insight: Craig Steger and Oded Ben-Joseph, PhD, MBA
As a highly specialized life science advisory and investment banking firm, Outcome Capital looks to identify emerging trends that effect how researchers and clinicians understand, diagnose, and treat disease. One emerging trend we have noted is the integration of advancements in biological sciences, such as tools and techniques, and digital technolo- gies, such as machine learning (ML) and artificial intelligence (AI). This merger has given rise to a new field – spatial biology.
Macroeconomic uncertainty, confusion surrounding the diagnostic regulatory landscape, and the continuing post-COVID-19 pandemic hangover have all contributed to a stagnant, quiet period for mergers and acquisitions in the in vitro diagnostics space in the first half of 2024.
Read MoreOutcome Capital Life Science Market Pulse June 2024 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?